Search

Search Constraints

You searched for: Author/Creator Mebazaa, Alexandre

Search Results

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. (27th January 2022)

2. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. (27th August 2021)

3. A case-control, multicentre study of consecutive patients with COVID-19 and acute (myo)pericarditis: incidence, risk factors, clinical characteristics and outcomes. Issue 5 (18th March 2022)

4. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term Registry. (10th January 2022)

5. A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2). Issue 2 (6th February 2019)

6. A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2). Issue 2 (6th February 2019)

7. A NOVEL URINARY BIOMARKER PREDICTS 1 YEAR MORTALITY AFTER DISCHARGE FROM INTENSIVE CARE. (April 2021)

8. A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus. (15th December 2019)

9. A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients. (June 2021)

10. Accuracy of cumulative volumes of fluid challenge to assess fluid responsiveness in critically ill patients with acute circulatory failure: a pharmacodynamic approach. (February 2022)